Skip to content

News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter

Search

Acute Leukemia

March 30, 2016

Vyxeos™ Improves Survival for Elderly in AML

Dr. C H Weaver MD
December 16, 2015

Addition of Rituxan Improves Outcomes in Some Acute Lymphoblastic Leukemias

Dr. C H Weaver MD
October 26, 2015

Cyclosporin A Reduces Anthracycline Resistance in Acute Myeloid Leukemia

Dr. C H Weaver MD
February 18, 2015

Intravenous Administration of Erwinaze® Approved by FDA

Dr. C H Weaver MD
December 8, 2014

Actinium Receives Orphan-drug Designation from FDA for Actimab-A

Dr. C H Weaver MD
January 18, 2013

CPX-351 Highly Active in Older Patients with AML

Dr. C H Weaver MD
August 17, 2012

Marqibo Approved for Treatment of Philadelphia-Negative ALL

Dr. C H Weaver MD
April 20, 2012

One Subset of Acute Lymphoblastic Leukemia is Best Treated with Chemotherapy

Dr. C H Weaver MD
January 1, 2012

Acute Myeloid Leukemia Screening/Prevention Overview

Dr. C H Weaver MD
June 14, 2011

Dacogen Effective for Treating Elderly Patients with Acute Myeloid Leukemia AML

Dr. C H Weaver MD
July 28, 2010

Newly Diagnosed Ph+ ALL Patients Benefit from Sprycel Chemotherapy Combination

Dr. C H Weaver MD
May 5, 2009

Compressed Dose-dense Induction with S-HAM Effective for AML Patients

Dr. C H Weaver MD

1 2 3 4 5 6 … 9

Sitemap
About Us
Advertising
Privacy Policy

Loading Comments...

Write a Comment...

Email (Required)

Name (Required)

Website